Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy (vol 99, pg 1050, 2008)

MLA

Pare, L., et al. Pharmacogenetic Prediction of Clinical Outcome in Advanced Colorectal Cancer Patients Receiving Oxaliplatin/5-Fluorouracil as First-Line Chemotherapy (Vol 99, Pg 1050, 2008). Jan. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....1697c7dc596eb5c770b7cd23cfe5c7df&authtype=sso&custid=ns315887.

APA

Pare, L., Marcuello, E., Altes, A., del Rio, E., Sedano, L., Salazar, J., Cortes, A., Barnadas, A., & Baiget, M. (2009). Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy (vol 99, pg 1050, 2008).

Chicago

Pare, L, E Marcuello, A Altes, E del Rio, L Sedano, J Salazar, A Cortes, A Barnadas, and M Baiget. 2009. “Pharmacogenetic Prediction of Clinical Outcome in Advanced Colorectal Cancer Patients Receiving Oxaliplatin/5-Fluorouracil as First-Line Chemotherapy (Vol 99, Pg 1050, 2008),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....1697c7dc596eb5c770b7cd23cfe5c7df&authtype=sso&custid=ns315887.